Evidence map›Paper›PMID 20876729›Full record

ArticleCancer prevention research (Philadelphia, Pa.)2010

Loss of inositol polyphosphate 5-phosphatase is an early event in development of cutaneous squamous cell carcinoma.

Aleksandar Sekulic, Su Y Kim, Galen Hostetter, Stephanie Savage, Janine G Einspahr, Anil Prasad, Paul Sagerman, Clara Curiel-Lewandrowski, Robert Krouse, G Timothy Bowden and 7 more

Open access · bronzeAbstract read
In one paragraph

Article in Cancer prevention research (Philadelphia, Pa.), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Frequent loss of inositol polyphosphate-5-phosphatase in oropharyngeal squamous cell carcinoma.Journal of the European Academy of Dermatology and Venereology : JEADV · 2018
    Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 5 institutions in 1 country.

Aleksandar SekulicMayo Clinic College of Medicine, Scottsdale, Arizona, USA.
Su Y Kim
Galen Hostetter
Stephanie Savage
Janine G Einspahr
Anil Prasad
Paul Sagerman
Clara Curiel-Lewandrowski
Robert Krouse
G Timothy Bowden
James Warneke
David S Alberts
Mark R Pittelkow
David DiCaudo
Brian J Nickoloff
Jeffrey M Trent
Michael Bittner
Mayo Clinic · USTranslational Genomics Research Institute · USLoyola University Medical Center · USMayo Clinic in Arizona · USUniversity of Arizona · US

Funding

VITAMIN A, AND ITS PRECURSORS AND DERIVATIVES AS THERAPEUTIC MODALITIESP01CA027502 · NCI · UNIVERSITY OF ARIZONA · PI EINSPAHR, JANINE G · 1985 to 2015
$36.3M
NCI NIH HHS 5P01CA027502-27NCI NIH HHS P01 CA027502
6 · The paper itself

Abstract

Cutaneous squamous cell carcinoma (SCC) occurs commonly and can metastasize. Identification of specific molecular aberrations and mechanisms underlying the development and progression of cutaneous SCC may lead to better prognostic and therapeutic approaches and more effective chemoprevention strategies. To identify genetic changes associated with early stages of cutaneous SCC development, we analyzed a series of 40 archived skin tissues ranging from normal skin to invasive SCC. Using high-resolution array-based comparative genomic hybridization, we identified deletions of a region on chromosome 10q harboring the INPP5A gene in 24% of examined SCC tumors. Subsequent validation by immunohistochemistry on an independent sample set of 71 SCC tissues showed reduced INPP5A protein levels in 72% of primary SCC tumors. Decrease in INPP5A protein levels seems to be an early event in SCC development, as it also is observed in 9 of 26 (35%) examined actinic keratoses, the earliest stage in SCC development. Importantly, further reduction of INPP5A levels is seen in a subset of SCC patients as the tumor progresses from primary to metastatic stage. The observed frequency and pattern of loss indicate that INPP5A, a negative regulator of inositol signaling, may play a role in development and progression of cutaneous SCC tumors.

Indexed as

Carcinoma, Squamous CellComparative Genomic HybridizationGene DosageHumansImmunohistochemistryInositol Polyphosphate 5-PhosphatasesIn Situ Hybridization, FluorescenceOligonucleotide Array Sequence AnalysisPhosphoric Monoester HydrolasesSkin NeoplasmsInositol Polyphosphate 5-PhosphatasesINPP5A protein, humanPhosphoric Monoester Hydrolases

Identifiers

PMID20876729
PMCPMC2955780
OpenAlexW2133223718

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.